Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026)
Zai Lab's (ZLAB) quarterly Total Non-Current Liabilities came in at $433.7 million in Q1 2026, up 19.73% year-on-year from $362.3 million in Q1 2025, and down 5.07% quarter-over-quarter from $456.9 million in Q4 2025.
Zai Lab (ZLAB) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
Zai Lab has disclosed Total Non-Current Liabilities across 5 years of filings, most recently posting $433.7 million for Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $433.7 million, up 19.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $433.7 million (up 19.73% YoY), and the FY2025 annual result was $456.9 million, up 32.61% from the prior year.
- Total Non-Current Liabilities came in at $433.7 million for Q1 2026 at Zai Lab, down from $456.9 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $456.9 million in Q4 2025 to a low of $162.4 million in Q3 2023.
- The 5-year median for Total Non-Current Liabilities is $300.1 million (2024), against an average of $293.8 million.
- Across the five-year window, Total Non-Current Liabilities surged 95.43% in 2024 and rose 19.73% in 2026, its largest moves.
- Zai Lab's Total Non-Current Liabilities stood at $174.5 million in 2022, then jumped by 37.42% to $239.9 million in 2023, then soared by 43.64% to $344.5 million in 2024, then jumped by 32.61% to $456.9 million in 2025, then dropped by 5.07% to $433.7 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $433.7 million (Q1 2026), $456.9 million (Q4 2025), and $398.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 11.03 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 95.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 644,700.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 5.87 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 64.76 Mn |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | 433.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 433.72 Mn |
| Dec 31, 2025 | 456.88 Mn |
| Sep 30, 2025 | 398.67 Mn |
| Jun 30, 2025 | 372.04 Mn |
| Mar 31, 2025 | 362.25 Mn |
| Dec 31, 2024 | 344.53 Mn |
| Sep 30, 2024 | 317.35 Mn |
| Jun 30, 2024 | 282.86 Mn |
| Mar 31, 2024 | 225.94 Mn |
| Dec 31, 2023 | 239.85 Mn |
| Sep 30, 2023 | 162.39 Mn |
| Jun 30, 2023 | 173.73 Mn |
| Mar 31, 2023 | 168.51 Mn |
| Dec 31, 2022 | 174.55 Mn |